212 related articles for article (PubMed ID: 8090784)
1. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus.
Valera A; Pujol A; Pelegrin M; Bosch F
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):9151-4. PubMed ID: 8090784
[TBL] [Abstract][Full Text] [Related]
2. Examination of the phosphoenolpyruvate carboxykinase gene promoter in patients with noninsulin-dependent diabetes mellitus.
Ludwig DS; Vidal-Puig A; O'Brien RM; Printz RL; Granner DK; Moller DE; Flier JS
J Clin Endocrinol Metab; 1996 Feb; 81(2):503-6. PubMed ID: 8636258
[TBL] [Abstract][Full Text] [Related]
3. Phosphoenolpyruvate carboxykinase (GTP) gene transcription and hyperglycemia are regulated by glucocorticoids in genetically obese db/db transgenic mice.
Friedman JE; Sun Y; Ishizuka T; Farrell CJ; McCormack SE; Herron LM; Hakimi P; Lechner P; Yun JS
J Biol Chem; 1997 Dec; 272(50):31475-81. PubMed ID: 9395482
[TBL] [Abstract][Full Text] [Related]
4. Peripheral insulin resistance develops in transgenic rats overexpressing phosphoenolpyruvate carboxykinase in the kidney.
Lamont BJ; Andrikopoulos S; Funkat A; Favaloro J; Ye JM; Kraegen EW; Howlett KF; Zajac JD; Proietto J
Diabetologia; 2003 Oct; 46(10):1338-47. PubMed ID: 12898008
[TBL] [Abstract][Full Text] [Related]
5. Merit of physical exercise to reverse the higher gene expression of hepatic phosphoenolpyruvate carboxykinase in obese Zucker rats.
Chang SP; Chen YH; Chang WC; Liu IM; Cheng JT
Life Sci; 2006 Jun; 79(3):240-6. PubMed ID: 16458327
[TBL] [Abstract][Full Text] [Related]
6. Prevention of diabetic alterations in transgenic mice overexpressing Myc in the liver.
Riu E; Bosch F; Valera A
Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2198-202. PubMed ID: 8700908
[TBL] [Abstract][Full Text] [Related]
7. Glucose metabolism in transgenic mice containing a chimeric P-enolpyruvate carboxykinase/bovine growth hormone gene.
Valera A; Rodriguez-Gil JE; Yun JS; McGrane MM; Hanson RW; Bosch F
FASEB J; 1993 Jun; 7(9):791-800. PubMed ID: 8330686
[TBL] [Abstract][Full Text] [Related]
8. Impaired glucose tolerance and increased weight gain in transgenic rats overexpressing a non-insulin-responsive phosphoenolpyruvate carboxykinase gene.
Rosella G; Zajac JD; Baker L; Kaczmarczyk SJ; Andrikopoulos S; Adams TE; Proietto J
Mol Endocrinol; 1995 Oct; 9(10):1396-404. PubMed ID: 8544847
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional analysis of the human phosphoenolpyruvate carboxykinase gene promoter.
O'Brien RM; Printz RL; Halmi N; Tiesinga JJ; Granner DK
Biochim Biophys Acta; 1995 Dec; 1264(3):284-8. PubMed ID: 8547315
[TBL] [Abstract][Full Text] [Related]
10. Overcoming diabetes-induced hyperglycemia through inhibition of hepatic phosphoenolpyruvate carboxykinase (GTP) with RNAi.
Gómez-Valadés AG; Vidal-Alabró A; Molas M; Boada J; Bermúdez J; Bartrons R; Perales JC
Mol Ther; 2006 Feb; 13(2):401-10. PubMed ID: 16271515
[TBL] [Abstract][Full Text] [Related]
11. Evidence from transgenic mice that myc regulates hepatic glycolysis.
Valera A; Pujol A; Gregori X; Riu E; Visa J; Bosch F
FASEB J; 1995 Aug; 9(11):1067-78. PubMed ID: 7649406
[TBL] [Abstract][Full Text] [Related]
12. Phenobarbital reduces blood glucose and gluconeogenesis through down-regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression in rats.
Oda H; Okuda Y; Yoshida Y; Kimura N; Kakinuma A
Biochem Biophys Res Commun; 2015 Oct; 466(3):306-11. PubMed ID: 26348778
[TBL] [Abstract][Full Text] [Related]
13. Regulated expression of human insulin in the liver of transgenic mice corrects diabetic alterations.
Valera A; Fillat C; Costa C; Sabater J; Visa J; Pujol A; Bosch F
FASEB J; 1994 Apr; 8(6):440-7. PubMed ID: 8168695
[TBL] [Abstract][Full Text] [Related]
14. Transcription of hepatic cytosolic phosphoenolpyruvate carboxykinase gene in newborn dogs.
Feng BC; Li J; Kliegman RM
Biochem Mol Med; 1996 Oct; 59(1):13-9. PubMed ID: 8902188
[TBL] [Abstract][Full Text] [Related]
15. Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver.
Burgess SC; He T; Yan Z; Lindner J; Sherry AD; Malloy CR; Browning JD; Magnuson MA
Cell Metab; 2007 Apr; 5(4):313-20. PubMed ID: 17403375
[TBL] [Abstract][Full Text] [Related]
16. A primary defect in glucose production alone cannot induce glucose intolerance without defects in insulin secretion.
Mangiafico SP; Lim SH; Neoh S; Massinet H; Joannides CN; Proietto J; Andrikopoulos S; Fam BC
J Endocrinol; 2011 Sep; 210(3):335-47. PubMed ID: 21700659
[TBL] [Abstract][Full Text] [Related]
17. Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver.
Ferre T; Riu E; Bosch F; Valera A
FASEB J; 1996 Aug; 10(10):1213-8. PubMed ID: 8751724
[TBL] [Abstract][Full Text] [Related]
18. Metabolic effects of developmental, tissue-, and cell-specific expression of a chimeric phosphoenolpyruvate carboxykinase (GTP)/bovine growth hormone gene in transgenic mice.
McGrane MM; Yun JS; Moorman AF; Lamers WH; Hendrick GK; Arafah BM; Park EA; Wagner TE; Hanson RW
J Biol Chem; 1990 Dec; 265(36):22371-9. PubMed ID: 1702419
[TBL] [Abstract][Full Text] [Related]
19. Lithium inhibits hepatic gluconeogenesis and phosphoenolpyruvate carboxykinase gene expression.
Bosch F; Rodriguez-Gil JE; Hatzoglou M; Gomez-Foix AM; Hanson RW
J Biol Chem; 1992 Feb; 267(5):2888-93. PubMed ID: 1371108
[TBL] [Abstract][Full Text] [Related]
20. Generation of fibroblasts overexpressing liver-specific PEPCK in a miniature pig model of human type 2 diabetes mellitus.
Kim YK; Lee GS; Jung EM; Hyun SH; Hwang WS; Jeung EB
Mol Med Rep; 2012 Jul; 6(1):45-50. PubMed ID: 22576736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
